SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WeirdPro Randy who wrote (373)5/28/1997 10:36:00 PM
From: IN_GOD_I_TRUST   of 998
 
But when would be the stock be at its greater value, right on approval or two months after some profits are sales can be better gauged? I would venture to guess two months later.

On top of this they have another drug coming to bat around this time frame with the FDA. If they had a fresh win with Myo and another drug coming around, most would be pretty confident IMO on the second approval, especially because its deemed as a stronger possibilty of getting thru already.

However you look at the investment, it was a bone head play. And no matter what the circumstances around the investment, it was perceived as a very cocky way of saying Myo would be approved by advisory board.

That was the perception of it regardless of CEPH motivation ... Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News